Uterine blood flow in pregnant patients with polycystic ovary syndrome: Relationships with clinical outcomes

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 6, 2010, Pages 711-721

  Palomba, S ^a   Falbo, A ^a   Russo, T ^a   Battista, L ^b   Tolino, A ^b   Orio, F ^c   Zullo, F ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

PCOS; Perinatal outcomes; Pregnancy outcomes; Ultrasound; Uterine blood flow; Velocimetry

Indexed keywords

ADULT; ARTICLE; BLOOD FLOWMETRY; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LASER FLOWMETER; MAJOR CLINICAL STUDY; MATERNAL AGE; OVARY POLYCYSTIC DISEASE; PERINATAL PERIOD; PREDICTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; UTERINE ARTERY; UTERUS BLOOD FLOW;

ADULT; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, DUPLEX; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY; UTERUS; VASCULAR RESISTANCE; YOUNG ADULT;

EID: 77950652671     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02525.x     Document Type: Article

References (43)

1. Frank S. Polycystic ovary syndrome. N Engl J Med 1995 333 : 853 861.
2. Huang A, Brennan K, Azziz R Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2009 [Epub ahead of print].
3. Liu S, Jiang JJ, Feng HL, Ma SY, Li M, Li Y Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system. Fertil Steril 2009 [Epub ahead of print].
4. Wood JR, Dumesic DA, Abbott DH, Strauss JF 3rd. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 2007 92 : 705 713. (Pubitemid 46255318)
5. Patel SS, Carr BR. Oocyte quality in adult polycystic ovary syndrome. Semin Reprod Med 2008 26 : 196 203. (Pubitemid 351342658)
6. Palomba S, Orio F Jr., Falbo A, Russo T, Tolino A, Zullo F. Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome. Fertil Steril 2006 86 : 1694 1701.
7. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod 1995 10 : 1962 1967.
8. Palomba S, Russo T, Orio F Jr., Falbo A, Manguso F, Cascella T, et al. Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome. Hum Reprod 2006 21 : 457 465. (Pubitemid 43159923)
9. Palomba S, Russo T, Orio F Jr., Falbo A, Manguso F, Sammartino A, et al. Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study. Hum Reprod 2006 21 : 2823 2829. (Pubitemid 44566993)
10. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006 12 : 673 683. (Pubitemid 44605508)
11. Wortsman J, de Angeles S, Futterweit W, Singh KB, Kaufmann RC. Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. J Reprod Med 1991 36 : 659 661.
12. Fridstrom M, Nisell H, Sjoblom P, Hillensjo T. Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia? Hypertens Pregnancy 1999 18 : 73 80. (Pubitemid 29149859)
13. Radon PA, McMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999 94 : 194 197. (Pubitemid 29352860)
14. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001 16 : 226 229. (Pubitemid 32149412)
15. Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod 2003 18 : 1438 1441. (Pubitemid 36840951)
16. Bjercke S, Dale PO, Tanbo T, Storeng R, Ertzeid G, Abyholm T. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest 2002 54 : 94 8. (Pubitemid 36164639)
17. Weerakiet S, Srisombut C, Rojanasakul A, Panburana P, Thakkinstian A, Herabutya Y. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome. Gynecol Endocrinol 2004 19 : 134 140. (Pubitemid 39486899)
18. Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburu B, Gazitua R, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 2005 20 : 2122 2126. (Pubitemid 41418494)
19. Brosens IA. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol 1977 4 : 573 593.
20. Prefumo F, Sebire NJ, Thilaganathan B. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum Reprod 2004 19 : 206 209. (Pubitemid 38072033)
21. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004 25 : 127 139. (Pubitemid 38258173)
22. Espinoza J, Romero R, Mee Kim Y, Kusanovic JP, Hassan S, Erez O, et al. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 2006 34 : 447 458. (Pubitemid 44877386)
23. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006 27 : 939 958. (Pubitemid 44204033)
24. Palomba S, Falbo A, Russo T, Tolino A, Orio F, Zullo F Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril. [Epub ahead of print]
25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 81 : 19 25. (Pubitemid 38058321)
26. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961 21 : 1440 1447.
27. Palomba S, Orio F Jr., Colao A, Di Carlo C, Sena T, Lombardi G, et al. Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002 87 : 1502 1508.
28. Legro RS, Fineggod D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998 83 : 2694 2698.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 419.
30. Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, et al. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003 88 : 3626 3631.
31. Morley JE, Patrick P, Perry HM III. Evaluation of assays available to measure free testosterone. Metabolism 2002 51 : 554 559.
32. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003 26 : S103 5.
33. Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society of the Study of Hypertension in pregnancy (ISSHP). Hypertens Pregnancy 2001 20 : IX XIV.
34. Gómez O. Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 2006 28 : 802 808.
35. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001 18 : 583 586. (Pubitemid 34063054)
36. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986 93 : 1049 1059.
37. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008 178 : 701 711.
38. Gómez O, Martínez JM, Figueras F, Del Río M, Borobio V, Puerto B, et al. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol 2005 26 : 490 494.
39. Coleman MAG, McCowan LME, North RA. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women. Ultrasound Obstet Gynecol 2000 15 : 7 12.
40. Siassakos D, Wardle P. Polycystic ovary syndrome and pregnancy outcome: Red herring or red flag? BJOG 2007 114 : 922 932.
41. Palomba S, Falbo A, Zullo F, Orio F Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review. Endocr Rev 2009 30 : 1 50.
42. Metformin in pregnant PCOS women. ClinicalTrials.gov Identifier: NCT00159536.
43. Uterine artery blood flow in pregnant women with polycystic ovary syndrome treated with metformin. ClinicalTrials.gov Identifier: NCT00466622.